Hemagen Diagnostics, Inc.
HMGN · OTC
9/30/2012 | 9/30/2011 | 9/30/2010 | 9/30/2009 | |
|---|---|---|---|---|
| Market Cap | $465 | $464 | $927 | $1,219 |
| - Cash | $66 | $214 | $152 | $156 |
| + Debt | $5,027 | $4,719 | $4,448 | $4,479 |
| Enterprise Value | $5,425 | $4,970 | $5,223 | $5,541 |
| Revenue | $4,042 | $5,141 | $5,220 | $5,419 |
| % Growth | -21.4% | -1.5% | -3.7% | – |
| Gross Profit | $1,613 | $1,961 | $2,356 | $2,072 |
| % Margin | 39.9% | 38.1% | 45.1% | 38.2% |
| EBITDA | -$274 | -$284 | $429 | -$192 |
| % Margin | -6.8% | -5.5% | 8.2% | -3.5% |
| Net Income | -$907 | -$880 | -$156 | -$808 |
| % Margin | -22.4% | -17.1% | -3% | -14.9% |
| EPS Diluted | -0.059 | -0.06 | -0.01 | -0.05 |
| % Growth | 2.5% | -500% | 80% | – |
| Operating Cash Flow | -$359 | -$337 | -$183 | $17 |
| Capital Expenditures | -$91 | -$56 | -$74 | -$115 |
| Free Cash Flow | -$450 | -$394 | -$257 | -$98 |